U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C20H8Br4O10S2.2Na
Molecular Weight 837.997
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of SULFOBROMOPHTHALEIN SODIUM

SMILES

[Na+].[Na+].OC(=O)C1=C(Br)C(Br)=C(Br)C(Br)=C1C(C2=CC=C(O)C(=C2)S([O-])(=O)=O)=C3C=CC(=O)C(=C3)S([O-])(=O)=O

InChI

InChIKey=HXUITPQMHVLBNV-LIYVDSPJSA-L
InChI=1S/C20H10Br4O10S2.2Na/c21-16-14(15(20(27)28)17(22)19(24)18(16)23)13(7-1-3-9(25)11(5-7)35(29,30)31)8-2-4-10(26)12(6-8)36(32,33)34;;/h1-6,25H,(H,27,28)(H,29,30,31)(H,32,33,34);;/q;2*+1/p-2/b13-8+;;

HIDE SMILES / InChI

Molecular Formula C20H8Br4O10S2
Molecular Weight 792.018
Charge -2
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
MOL RATIO 2 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Sulfobromophthalein (BSP) is a dye with a high affinity for organic anion transporting polypeptides (OATPs) and has been used as a substrate for multidrug resistance associated protein 2 (Mrp2). BSP is transported into hepatocytes by OATPs and, after conjugation to glutathione, is excreted into bile by Mrp2.3 It was found to inhibit the aldo-keto reductase ARK1C20. Sulfobromophthalein (BSP) is used in diagnosis of hepatic disorders.It is also used for the quantitative determination of proteins.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
44.0 nM [Ki]
2.18 µM [Ki]
1.0 µM [IC50]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Bromosulfoftaleina Sodium

AUC

ValueDoseCo-administeredAnalytePopulation
0.943 mg × min/mL
20 mg/kg single, intravenous
SULFOBROMOPHTHALEIN plasma
Rattus norvegicus
1551.5 μg × min/mL
20 mg/kg single, intravenous
SULFOBROMOPHTHALEIN plasma
Rattus norvegicus

T1/2

ValueDoseCo-administeredAnalytePopulation
3.07 min
20 mg/kg single, intravenous
SULFOBROMOPHTHALEIN plasma
Rattus norvegicus

Doses

AEs

Overview

CYP3A4CYP2C9CYP2D6hERG

Drug as perpetrator​

Drug as victim

PubMed

Sample Use Guides

In Vivo Use Guide
Rats: 350mg/day, i.v.
Route of Administration: Intravenous
In Vitro Use Guide
In competitive binding studies in vitro between Sulfobromophthalein (BSP) and a series of organic anions (sodium fluorescein, indocyanine green, bilirubin, sodium taurocholate, flavaspidic acid glucaminate, and iodipamide methylglucamine), the incubation mixture contained 500 ug of BSP and equimolar amounts of the aforementional organic anions. On the average, 160 +/- 2 ug BSP was bound per mg of membrane protein and 1.4 +/-0.1 ug BSP bound per unit of Co++-CMPase activity in 15 membrane isolates. BSP binding was maximal at 500 ug BSP/ml in the incubation mix with proportionately less binding observed at lower concentrations. BSP concentrations above 500 ug/ml reduced BSP binding and produced dissolution of cell membranes.
Substance Class Chemical
Record UNII
62E5JU30OV
Record Status Validated (UNII)
Record Version